Immune Response to Shingles Vaccination

A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine

NCT06581575 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults

NCT05703607 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)

NCT00322231 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years

NCT04072497 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020

NCT01911065 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)

NCT01254630 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection

NCT00338442 ·Status: APPROVED_FOR_MARKETING

A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)

NCT00231816 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)

NCT01229267 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)

NCT00534248 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Immunogenicity and Safety Study of GSKs Recombinant Zoster Vaccine Shingrix (GSK1437173A) in Chinese Adults Aged ≥50 Years

NCT04869982 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate Immunogenicity, Safety, and Tolerability of ZOSTAVAX™ Vaccine (Zoster Vaccine Live, V211) Administered Concomitantly Versus Nonconcomitantly With Quadrivalent Influenza Virus Vaccine (Inactivated) in Participants ≥50 Years of Age (V211-062)

NCT02519855 ·Status: COMPLETED ·Phase: PHASE3

ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)

NCT01600079 ·Status: COMPLETED

A Study Exploring the Use of Vaccine and Antigen Challenges for Immune Monitoring in Healthy Participants

NCT03953196 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With Hematologic Malignancies (HM) Receiving Treatment With Anti-Cluster of Differentiation (CD) 20 Monoclonal Antibodies (V212-013)

NCT01460719 ·Status: COMPLETED ·Phase: PHASE1

A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002)

NCT00535236 ·Status: COMPLETED ·Phase: PHASE1

A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine

NCT05871541 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)

NCT00130793 ·Status: COMPLETED ·Phase: PHASE3

Optimal Timing of Zoster Vaccine After Zoster Illness

NCT02704572 ·Status: COMPLETED ·Phase: NA

Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents

NCT01262300 ·Status: COMPLETED ·Phase: PHASE1

Persistence of Protection by Shingrix

NCT04169009 ·Status: COMPLETED ·Phase: PHASE4

Immunogenicity, Efficacy and Safety of Recombinant Herpes Zoster Vaccine in Frail Patients

NCT07321808 ·Status: RECRUITING

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IV Clinical Trial to Evaluate the Immunogenicity and Safety of a Live Attenuated Herpes Zoster Vaccine in Adults Aged 40 Years and Older

NCT06961721 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants

NCT06375512 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043)

NCT00561080 ·Status: COMPLETED ·Phase: PHASE3